Alpha Tau Company Webcast @ Lytham Partners Fall 2025 Investor Conference
As part of the Lytham Partners Fall 2025 Investor Conference, Robert Blum, Managing Partner, Lytham Partners, hosted a virtual company presentation with Alpha Tau. Alpha Tau is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into solid tumors. For more information on our investor events, visit https://lythampartners.com/virtual/ Please read our disclaimer/disclosure statement at https://lythampartners.com/disclosures/.
▶︎
Alpha Tau Medical (DRTS) Investor Presentation | Lytham Partners Spring 2026 Investor Conference
▶︎
Meet the Former CIA Agent Who Wants to Abolish the CIA
▶︎
Yann LeCun: World Models: Enabling the next AI revolution
▶︎
An Integrative, Pathology-Centered Perspective on Anal, Oral and Oropharyngeal HPV in Women
▶︎
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List
▶︎
The World's Most Important Machine
▶︎
U.S. Antimony (UAMY) Investor Presentation | Lytham Partners Spring 2026 Investor Conference
▶︎
The French Do Not Care About Work
▶︎
KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease (2025)
▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎
Webcast: Florida Viral Hepatitis Network: Hepatitis Elimination Series Part 2
▶︎
SKYX Platforms (SKYX) Investor Presentation | Lytham Partners Spring 2026 Investor Conference
▶︎
The Uncomfortable Truth About AI “Reasoning” | World Science Festival
▶︎
MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints
▶︎
Arianne Phosphate Investor Presentation: Strategy, Growth, and Market Outlook
▶︎
Power BI FULL COURSE for Beginners | Learn Dashboards & Reports Fast!
▶︎
Reviva Pharmaceuticals Fireside Chat @ Lytham Partners Fall 2025 Investor Conference
▶︎
WEBINAR: Formulating the Future Longevity, Minimalism & the Science of Less
▶︎
Saliva, Blood, or Urine? Choosing The Right Hormone Test – A Functional Medicine Approach
▶︎